CorMedix (CRMD) News Today $7.98 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$7.97 -0.01 (-0.13%) As of 05/22/2026 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRMD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period CorMedix Eyes REZZAYO Expansion as DefenCath Reimbursement Shift LoomsMay 22 at 6:03 AM | marketbeat.comUBS Group AG Sells 454,873 Shares of CorMedix Inc $CRMDMay 19, 2026 | marketbeat.comCorMedix: Long-Term Prospects Remain Poor Despite Q1 BeatMay 18, 2026 | seekingalpha.comDoes Strong Q1 Beat And Raised Outlook Transform The Bull Case For CorMedix (CRMD)?May 18, 2026 | finance.yahoo.comHC Wainwright Forecasts CorMedix's Q2 Earnings (NASDAQ:CRMD)May 18, 2026 | marketbeat.comA Look At CorMedix (CRMD) Valuation After Strong Q1 2026 Results And Raised Full Year GuidanceMay 16, 2026 | finance.yahoo.comCorMedix Inc $CRMD Shares Bought by Vanguard Group Inc.May 16, 2026 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Cormedix (CRMD)May 15, 2026 | theglobeandmail.comCormedix Therapeutics to Participate in two Upcoming Investor ConferencesMay 15, 2026 | globenewswire.comCormedix Inc (CRMD) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...May 15, 2026 | finance.yahoo.comCRMD stock soared 18% today – here’s what fueled CorMedix’s triple-digit Q1 revenue surgeMay 14, 2026 | msn.comCorMedix (CRMD) Q1 2026 Earnings TranscriptMay 14, 2026 | finance.yahoo.comCorMedix (NASDAQ:CRMD) Issues Earnings ResultsMay 14, 2026 | marketbeat.comCorMedix Inc. (CRMD) Q1 2026 Earnings Call TranscriptMay 14, 2026 | seekingalpha.comCorMedix shares jump after revenue beat and higher full-year guidanceMay 14, 2026 | msn.comCorMedix Q1 Earnings Call HighlightsMay 14, 2026 | marketbeat.comCormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 14, 2026 | globenewswire.comHow The CorMedix (CRMD) Story Is Shifting As Analysts Split On US$13–US$15 TargetsMay 11, 2026 | finance.yahoo.comCorMedix Inc (NASDAQ:CRMD) Receives Consensus Rating of "Moderate Buy" from AnalystsMay 6, 2026 | marketbeat.comCorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026May 5, 2026 | globenewswire.com210,831 Shares in CorMedix Inc $CRMD Acquired by Del Sette Capital Management LLCMay 2, 2026 | marketbeat.comCorMedix (CRMD) Expected to Announce Earnings on WednesdayApril 29, 2026 | marketbeat.comCorMedix (NASDAQ:CRMD) Earns Market Outperform Rating from Citizens JmpApril 28, 2026 | marketbeat.comCorMedix (NASDAQ:CRMD) Price Target Raised to $14.00April 28, 2026 | marketbeat.comCRMD stock jumps as antifungal drug clears key trial for $2B preventive marketApril 28, 2026 | msn.comCorMedix (NASDAQ:CRMD) Price Target Raised to $15.00April 27, 2026 | marketbeat.comCorMedix (NASDAQ:CRMD) Earns Buy Rating from D. Boral CapitalApril 27, 2026 | marketbeat.comCorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic ...April 27, 2026 | markets.businessinsider.comCorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation PatientsApril 27, 2026 | globenewswire.comHow The CorMedix (CRMD) Story Is Shifting With Lower Guidance And Mixed Analyst TargetsApril 8, 2026 | finance.yahoo.comCorMedix: A Shrinking Core And No Proven Second EngineApril 8, 2026 | seekingalpha.comCorMedix to Participate in Needham Virtual Healthcare ConferenceApril 7, 2026 | globenewswire.comCorMedix: Waiting On Phase III ReSPECT For A Further Re-Rating (Upgrade)April 2, 2026 | seekingalpha.comDo options traders know something about CorMedix stock we don't?March 26, 2026 | msn.comHow The CorMedix (CRMD) Investment Story Is Shifting As Analyst Targets ResetMarch 24, 2026 | finance.yahoo.comAssessing CorMedix (CRMD) Valuation After Recent Share Price Weakness And Growth ExpectationsMarch 7, 2026 | finance.yahoo.comCorMedix Inc. (NASDAQ:CRMD) Q4 2025 earnings call transcriptMarch 6, 2026 | msn.comCorMedix Buyback And REZZAYO Data Shape Valuation And Risk ProfileMarch 6, 2026 | finance.yahoo.comCormedix Inc (CRMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...March 5, 2026 | finance.yahoo.comCorMedix nears an 11-month low after earnings missMarch 5, 2026 | seekingalpha.comCorMedix (CRMD) Q4 2025 Earnings Call TranscriptMarch 5, 2026 | fool.comCorMedix Inc. (CRMD) Q4 2025 Earnings Call TranscriptMarch 5, 2026 | seekingalpha.comCorMedix stock falls 5% on fourth quarter earnings missMarch 5, 2026 | in.investing.comCorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateMarch 5, 2026 | globenewswire.comCorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026March 2, 2026 | globenewswire.comIs It Time To Revisit CorMedix (CRMD) After Its Sharp Year To Date Decline?March 1, 2026 | finance.yahoo.comCorMedix Inc. (CRMD) Analyst/Investor Day TranscriptFebruary 14, 2026 | seekingalpha.comCorMedix to Participate in Upcoming Investor ConferencesFebruary 12, 2026 | globenewswire.comCorMedix Inc. (CRMD) Board Approves Multi-Year $75M Stock BuybackFebruary 11, 2026 | insidermonkey.comCorMedix Inc. (CRMD) board approves multi-year $75M stock buybackFebruary 11, 2026 | msn.com Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRMD Media Mentions By Week CRMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRMD News Sentiment▼0.810.45▲Average Medical News Sentiment CRMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRMD Articles This Week▼46▲CRMD Articles Average Week Get the Latest News and Ratings for CRMD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CorMedix and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies VERA News ELVN News NBTX News RARE News RLAY News IMNM News KOD News MLYS News ZLAB News TYRA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRMD) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share CorMedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
